{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:50:08Z","timestamp":1794030608619,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82403381"],"award-info":[{"award-number":["82403381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82030099"],"award-info":[{"award-number":["82030099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sailing Program of Shanghai Rising-Star Program","award":["24YF2722700"],"award-info":[{"award-number":["24YF2722700"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFD2101500"],"award-info":[{"award-number":["2022YFD2101500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020732","name":"Innovative research team of high-level local universities in Shanghai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2026ZB0556800"],"award-info":[{"award-number":["2026ZB0556800"]}]},{"name":"Medical-Engineering Cross Foundation of Shanghai Jiao Tong University","award":["YG2025LC14"],"award-info":[{"award-number":["YG2025LC14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03208-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:36:31Z","timestamp":1783172191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanqiu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangyi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchen","family":"Lhamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"Suppl","key":"3208_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32-s50.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"3208_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3208_CR3","doi-asserted-by":"crossref","unstructured":"Wang J, Tu G, Tao Q, Li R, Zhai H, Hong S, Shi X, Zhang G. The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies. Cardiovasc Diabetol. 2026.","DOI":"10.1186\/s12933-026-03171-7"},{"key":"3208_CR4","doi-asserted-by":"crossref","unstructured":"Assempoor R, Jodeiri F, Javadi M, Seighali N, Shenava SAS, Najafi K, Antoun I, Hassanabad AF, Kuno T, Biering-S\u00f8rensen T et al. Association of the C-reactive protein\u2013triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study. Cardiovasc Diabetol. 2026.","DOI":"10.1186\/s12933-026-03163-7"},{"issue":"9","key":"3208_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691\u2013705.","journal-title":"Gut"},{"issue":"2","key":"3208_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4070\/kcj.2025.0212","volume":"56","author":"MG Suresh","year":"2026","unstructured":"Suresh MG, Mohamed S, Geetha HS, Prabhu S, Trivedi N, Mehta PD, et al. Cardiovascular implications in metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. Korean Circ J. 2026;56(2):103\u201330.","journal-title":"Korean Circ J"},{"issue":"1","key":"3208_CR7","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v18.i1.111954","volume":"18","author":"AS Brar","year":"2026","unstructured":"Brar AS, Khanna T, Sohal A, Hatwal J, Sharma V, Singh C, et al. Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: a state-of-the-art review. World J Cardiol. 2026;18(1):111954.","journal-title":"World J Cardiol"},{"issue":"7","key":"3208_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4330\/wjc.v16.i7.380","volume":"16","author":"A Batta","year":"2024","unstructured":"Batta A, Hatwal J. Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: a cause for concern! World J Cardiol. 2024;16(7):380\u20134.","journal-title":"World J Cardiol"},{"issue":"8","key":"3208_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao Y-Y, Zheng M-H. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"3208_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):262.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12944-024-02408-2","volume":"23","author":"M Liu","year":"2024","unstructured":"Liu M, Wang C, Liu R, Wang Y, Wei B. Association between cardiometabolic index and all-cause and cause-specific mortality among the general population: NHANES 1999\u20132018. Lipids Health Dis. 2024;23(1):425.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3208_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12933-024-02359-z","volume":"23","author":"M Qin","year":"2024","unstructured":"Qin M, Chen B. Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005\u20132018. Cardiovasc Diabetol. 2024;23(1):255.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, Zhao X, Li S, Miao G, Bai L, Zhang Q, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2024;23(1):243.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng l, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-025-03043-6","volume":"25","author":"C Yu","year":"2026","unstructured":"Yu C, Qiu C, Zhang Q, Wang W, Liu S, Jin Z. Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2026;25(1):74.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-02033-8","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yu Q. METS-IR predicts new-onset stroke in older adults with stages 0\u20133 cardiovascular-kidney-metabolic syndrome: a prospective, multicohort, clinical study with statistical and machine learning. Diabetol Metab Syndr. 2025;18(1):6.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3208_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s44220-023-00158-1","volume":"2","author":"R-Z Wang","year":"2024","unstructured":"Wang R-Z, He Y, Deng Y-T, Wang H-F, Zhang Y, Feng J-F, et al. Body weight in neurological and psychiatric disorders: a large prospective cohort study. Nat Ment Health. 2024;2(1):41\u201351.","journal-title":"Nat Ment Health"},{"issue":"1","key":"3208_CR19","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2666-7568(23)00220-9","volume":"5","author":"L Chen","year":"2024","unstructured":"Chen L, Wu B, Mo L, Chen H, Zhao Y, Tan T, et al. Associations between biological ageing and the risk of, genetic susceptibility to, and life expectancy associated with rheumatoid arthritis: a secondary analysis of two observational studies. Lancet Healthy Longev. 2024;5(1):e45\u201355.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"3208_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12933-024-02251-w","volume":"23","author":"B Xu","year":"2024","unstructured":"Xu B, Wu Q, La R, Lu L, Abdu FA, Yin G, et al. Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study. Cardiovasc Diabetol. 2024;23(1):212.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-024-02228-9","volume":"23","author":"H Yan","year":"2024","unstructured":"Yan H, Zhou Q, Wang Y, Tu Y, Zhao Y, Yu J, et al. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2024;23(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3208_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.124.24252","volume":"82","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wan T, Hong Y, Wang X, Jiang X, Yang \u6768\u6d0bY, et al. Impact of NAFLD and fibrosis on adverse cardiovascular events in patients with hypertension. Hypertension. 2025;82(6):1012\u201323.","journal-title":"Hypertension"},{"issue":"1","key":"3208_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-025-02698-5","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, Chen K, Tang M, Mu Q, Zhang S, Li J, et al. Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes. Cardiovasc Diabetol. 2025;24(1):145.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3208_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2013.02.010","volume":"42","author":"RR Kalyani","year":"2013","unstructured":"Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. 2013;42(2):333\u201347.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"3208_CR25","doi-asserted-by":"publisher","first-page":"e2230690","DOI":"10.1001\/jamanetworkopen.2022.30690","volume":"5","author":"G Yang","year":"2022","unstructured":"Yang G, Cao X, Li X, Zhang J, Ma C, Zhang N, et al. Association of unhealthy lifestyle and childhood adversity with acceleration of aging among UK Biobank participants. JAMA Netw Open. 2022;5(9):e2230690\u2013e2230690.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3208_CR26","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jcsm.13032","volume":"13","author":"M Song","year":"2022","unstructured":"Song M, Zhang Q, Song C, Liu T, Zhang X, Ruan G, et al. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. J Cachexia Sarcopenia Muscle. 2022;13(5):2504\u201314.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3208_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439231","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Huang R, Zhang P, Liu Y, Liu Z, He J, et al. Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1439231.","journal-title":"Front Immunol"},{"issue":"8","key":"3208_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride\/glucose index. Diabetes Metab Syndr. 2022;16(8):102581.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"3208_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12933-025-02695-8","volume":"24","author":"Q Yang","year":"2025","unstructured":"Yang Q, Zhu X, Zhang L, Luo F. Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration. Cardiovasc Diabetol. 2025;24(1):181.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3208_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):262.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3208_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1572-0241.2005.41500.x","volume":"100","author":"Z Yesilova","year":"2005","unstructured":"Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2005;100(4):850\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3208_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801585","volume":"6","author":"Y Yu","year":"2019","unstructured":"Yu Y, Cai J, She Z, Li H. Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases. Adv Sci (Weinh). 2019;6(4):1801585.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3208_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3208_CR36","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","volume":"99","author":"N Chalasani","year":"2004","unstructured":"Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99(8):1497\u2013502.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3208_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/clinchem\/47.5.887","volume":"47","author":"V Cavalca","year":"2001","unstructured":"Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem. 2001;47(5):887\u201392.","journal-title":"Clin Chem"},{"issue":"3","key":"3208_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4093\/dmj.2023.0350","volume":"48","author":"I Jung","year":"2024","unstructured":"Jung I, Koo DJ, Lee WY. Insulin resistance, non-alcoholic fatty liver disease and type 2 diabetes mellitus: clinical and experimental perspective. Diabetes Metab J. 2024;48(3):327\u201339.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"3208_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24(1):154.","journal-title":"Cardiovasc Diabetol"},{"key":"3208_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102294","volume":"97","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Gong Y, Zhu N, Shi Y, Zhang C, Qin L. Lipids and lipid metabolism in cellular senescence: emerging targets for age-related diseases. Ageing Res Rev. 2024;97:102294.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3208_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","volume":"24","author":"F Rossiello","year":"2022","unstructured":"Rossiello F, Jurk D, Passos JF, d\u2019Adda di Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022;24(2):135\u201347.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3208_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"issue":"15","key":"3208_CR43","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1016\/j.cell.2024.05.048","volume":"187","author":"HS Shim","year":"2024","unstructured":"Shim HS, Iaconelli J, Shang X, Li J, Lan ZD, Jiang S, et al. TERT activation targets DNA methylation and multiple aging hallmarks. Cell. 2024;187(15):4030-4042.e4013.","journal-title":"Cell"},{"issue":"4","key":"3208_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-019-1550-0","volume":"10","author":"J Fafi\u00e1n-Labora","year":"2019","unstructured":"Fafi\u00e1n-Labora J, Carpintero-Fern\u00e1ndez P, Jordan SJD, Shikh-Bahaei T, Abdullah SM, Mahenthiran M, et al. FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis. 2019;10(4):318.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3208_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s42255-023-00972-y","volume":"6","author":"K Tighanimine","year":"2024","unstructured":"Tighanimine K, Nabuco Leva Ferreira Freitas JA, Nemazanyy I, Bankol\u00e9 A, Benarroch-Popivker D, Brodesser S, et al. A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism. Nat Metab. 2024;6(2):323\u201342.","journal-title":"Nat Metab"},{"issue":"4","key":"3208_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/met.2019.0115","volume":"18","author":"K Lechner","year":"2020","unstructured":"Lechner K, McKenzie AL, Kr\u00e4nkel N, Von Schacky C, Worm N, Nixdorff U, et al. High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation. Metab Syndr Relat Disord. 2020;18(4):176\u201385.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"3208_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCRESAHA.109.208488","volume":"106","author":"I Tabas","year":"2010","unstructured":"Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res. 2010;106(1):58\u201367.","journal-title":"Circ Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03208-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03208-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03208-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:01:59Z","timestamp":1783332119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03208-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03208-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Biobank received ethical approval from the North West Multi-Center Research Ethics Committee (Approved Research ID: 194423, Approval date: October 30, 2024). All participants gave written informed consent before enrollment in the study, which was conducted in accordance with the principles of the Declaration of Helsinki. The National Center for Health Statistics and Ethics Review Board approved the protocol for NHANES, and all participants provided written informed consent. Research ethics approval was obtained from the Center for Disease Control and Prevention of the Pudong New Area, Shanghai, China. Each participant provided a written consent.\u00a0All participants were informed and agreed to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}